{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:36:10Z","timestamp":1790141770892,"version":"4.0.1"},"reference-count":21,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2002,5,22]],"date-time":"2002-05-22T00:00:00Z","timestamp":1022025600000},"content-version":"vor","delay-in-days":202,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2001,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background<\/jats:bold> Most clinical studies using photodynamic therapy (PDT) with topical application of \u03b4\u2010aminolaevulinic acid (\u03b4\u2010ALA) use red light because it allows greater depth of penetration. However, given the porphyrin\u2010like spectrum of \u03b4\u2010ALA\u2010induced photosensitivity, violet light provides a maximal overlap with the excitation spectrum of protoporphyrin IX, meaning that PDT with violet light uses less light energy to induce the phototoxic reaction.<\/jats:p><jats:p><jats:bold>Aim<\/jats:bold> To study the efficacy of violet light in combination with topical \u03b4\u2010ALA PDT in the treatment of premalignant and malignant skin lesions.<\/jats:p><jats:p><jats:bold>Methods<\/jats:bold> Eight hours after 20%\u03b4\u2010ALA was applied topically, photoirradiation was performed with an incoherent light source (Philips HPM\u201010, 400\u00a0W) emitting predominantly violet light (400\u2013450\u00a0nm). Lesions received 10\u201320\u00a0J\/cm<jats:sup>2<\/jats:sup> during an exposure time of 30\u00a0min. The 38 subjects treated included three with basal cell naevus syndrome with multiple (&gt;\u00a030) superficial and nodular basal cell carcinomas (BCCs), one subject had multiple lesions of Bowen\u2019s disease, involving 50% of the scalp, and the remaining 34 subjects presented a total of 35 superficial BCCs, 10 nodular BCCs, four large solar keratoses and five solitary lesions of Bowen\u2019s disease.<\/jats:p><jats:p><jats:bold>Results<\/jats:bold> Complete remission both clinically and histologically was seen after a single treatment in 82% of the superficial BCCs (100% after a second treatment), 50% of the nodular BCCs, one of the four solar keratosis lesions (partial remission in the other three) and 90\u2013100% of the solitary lesions of Bowen\u2019s disease.<\/jats:p><jats:p><jats:bold>Conclusions<\/jats:bold> \u03b4\u2010ALA PDT using violet light appears to be a well tolerated and effective alternative treatment for premalignant and malignant skin lesions, especially when there are multiple lesions or large patches comprising a large area of skin.<\/jats:p>","DOI":"10.1046\/j.1468-3083.2001.00333.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T04:41:23Z","timestamp":1047444083000},"page":"550-554","source":"Crossref","is-referenced-by-count":79,"title":["Photodynamic therapy with violet light and topical \u03b4\u2010aminolaevulinic acid in the treatment of actinic keratosis, Bowen\u2019s disease and basal cell carcinoma"],"prefix":"10.1111","volume":"15","author":[{"given":"AT","family":"Dijkstra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"IML","family":"Majoie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JWF","family":"Van Dongen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Van Weelden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WA","family":"Van Vloten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,5,22]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/1011-1344(92)85108-7"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5849(97)00370-5"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(92)90080-L"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/1011-1344(90)85083-9"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(93)70002-B"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1994.tb03412.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1994.112"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(08)81742-2"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1995.tb02630.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1159\/000246376"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1997.03890420065007"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-1097.1992.tb04222.x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1988.6.2.380"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/1011-1344(92)85128-H"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-1097.1984.tb04622.x"},{"key":"e_1_2_6_17_2","first-page":"S72","article-title":"Photodynamic therapy: which wavelength and what about DNA damage","volume":"12","author":"Van Vioten WA","year":"1999","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1997.01825.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1996.d01-1076.x"},{"key":"e_1_2_6_20_2","first-page":"245","article-title":"Protoporphyrin photosensitivity cannot be attenuated by oral N\u2010acetylcysteine","volume":"9","author":"Bijimer\u2010lest JC","year":"1992","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1011-1344(97)00096-1"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00371740"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1468-3083.2001.00333.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1468-3083.2001.00333.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T18:32:05Z","timestamp":1697653925000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1468-3083.2001.00333.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,11]]}},"alternative-id":["10.1046\/j.1468-3083.2001.00333.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1468-3083.2001.00333.x","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,11]]}}}